Itamar Medical Statistics
Share Statistics
Itamar Medical has 0
shares outstanding. The number of shares has increased by null%
in one year.
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | n/a |
| FTD / Avg. Volume | n/a |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -25.14 and the forward
PE ratio is null.
Itamar Medical's PEG ratio is
-0.35.
| PE Ratio | -25.14 |
| Forward PE | n/a |
| PS Ratio | 6.7 |
| Forward PS | n/a |
| PB Ratio | 6.39 |
| P/FCF Ratio | -24.89 |
| PEG Ratio | -0.35 |
Financial Ratio HistoryEnterprise Valuation
Itamar Medical has an Enterprise Value (EV) of 271.34M.
| EV / Sales | 6.61 |
| EV / EBITDA | -32.18 |
| EV / EBIT | -30.77 |
| EV / FCF | -24.56 |
Financial Position
The company has a current ratio of 3.19,
with a Debt / Equity ratio of 0.14.
| Current Ratio | 3.19 |
| Quick Ratio | 2.79 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | -0.71 |
| Debt / FCF | -0.54 |
| Interest Coverage | -18.41 |
Financial Efficiency
Return on Equity is -25.4% and Return on Invested Capital is -21.33%.
| Return on Equity | -25.4% |
| Return on Assets | -17.05% |
| Return on Invested Capital | -21.33% |
| Revenue Per Employee | $159,665.37 |
| Profits Per Employee | $-42,564.2 |
| Employee Count | 257 |
| Asset Turnover | 0.64 |
| Inventory Turnover | 1.72 |
Taxes
| Income Tax | 127K |
| Effective Tax Rate | -1.17% |
Stock Price Statistics
The stock price has increased by 0% in the
last 52 weeks. The beta is 0.54, so Itamar Medical's
price volatility has been higher than the market average.
| Beta | 0.54 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | 135,920 |
Income Statement
In the last 12 months, Itamar Medical had revenue of 41.03M
and earned -10.94M
in profits. Earnings per share was -0.79.
| Revenue | 41.03M |
| Gross Profit | 28.71M |
| Operating Income | -10.34M |
| Net Income | -10.94M |
| EBITDA | -8.43M |
| EBIT | -10.25M |
| Earnings Per Share (EPS) | -0.79 |
Full Income StatementBalance Sheet
The company has 9.67M in cash and 5.99M in
debt, giving a net cash position of 3.68M.
| Cash & Cash Equivalents | 9.67M |
| Total Debt | 5.99M |
| Net Cash | 3.68M |
| Retained Earnings | -119.07M |
| Total Assets | n/a |
| Working Capital | n/a |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -8.82M
and capital expenditures -2.23M, giving a free cash flow of -11.05M.
| Operating Cash Flow | -8.82M |
| Capital Expenditures | -2.23M |
| Free Cash Flow | -11.05M |
| FCF Per Share | -0.8 |
Full Cash Flow StatementMargins
Gross margin is 69.97%, with operating and profit margins of -25.21% and -26.66%.
| Gross Margin | 69.97% |
| Operating Margin | -25.21% |
| Pretax Margin | -26.35% |
| Profit Margin | -26.66% |
| EBITDA Margin | -20.55% |
| EBIT Margin | -25.21% |
| FCF Margin | -26.92% |
